Nathaniel B. Rieveschl

Nathaniel Rieveschl practices at Southpoint Surgery Center in Jacksonville, Florida.

Nathaniel Rieveschl's NPI, 1851854731, was assigned on April 9, 2019. Nathaniel Rieveschl graduated from Cleveland Medical College, Homeopathic in 2019. Nathaniel Rieveschl holds Florida license ME161961.

Nathaniel Rieveschl's primary practice is Southpoint Surgery Center, at 7051 Southpoint Parkway Suite 100, Jacksonville, FL 32216. The practice phone is (904) 854-4854.

Nathaniel Rieveschl's primary practice is Southpoint Surgery Center in Jacksonville, Florida. The medical group on file is UF Health Physicians. Dmand AI also links Nathaniel Rieveschl to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nathaniel Rieveschl practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Nathaniel Rieveschl's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Nathaniel Rieveschl is board certified in ophthalmology by the American Board of Ophthalmology. Nathaniel Rieveschl is licensed in Florida.

Dmand AI lists eyelid inflammation among the conditions Nathaniel Rieveschl treats.

CMS data shows 308 Medicare services from Nathaniel Rieveschl across 9 procedure codes in 2024, for 182 Medicare patients. Medicare paid $21,758 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Nathaniel Rieveschl in 2024. The largest group is 75 to 84, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Nathaniel Rieveschl's median patient age at 71, with 56% women.

In 2024, Nathaniel Rieveschl wrote 263 Medicare Part D claims for 128 patients. 73% of them were for generic drugs. CMS names the drug for 141 of them, across 7 drugs with 11 or more claims each, at $3,143 in total drug cost. In 2023, CMS named 219 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Nathaniel Rieveschl for performance year 2024, reported as part of a group. Nathaniel Rieveschl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 169 procedures of cataract surgery by Nathaniel Rieveschl, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Nathaniel Rieveschl, published from 2017 to 2022. 2017 was the busiest year, with 2. Nathaniel Rieveschl's most frequent co-authors are Amy Shrader Babiuch, MD, Justis P. Ehlers, MD and Andrew P. Schachat, MD.

CMS Open Payments shows 39 general payments to Nathaniel Rieveschl from 14 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 93% of the total. Harrow Eye, LLC paid the most, $258.

Nathaniel Rieveschl graduated from Cleveland Medical College, Homeopathic in 2019.

Nathaniel Rieveschl is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.